Lefèvre J P, Mueller T C, Rossi M. "一种左乙拉西坦杂质42的合成方法" [P]. European Patent, EP 3641536 A1, 2024-06-08.
发明人高志强,周伟,刘建华. "Method for the Synthesis of Levetiracetam Impurity 42" [P]. 中国发明专利, 专利号 CN 111057262 A, 授权公告日 2015-05-19.
Schröder R, Kumar R, Johnson M A. "A Process for Preparing High-Purity Levetiracetam Impurity 42" [P]. US Patent, US 11226183 B2, 2015-09-14.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 左乙拉西坦杂质42 in Pharmaceutical Formulations". Environ. Sci. Technol., 2010, 1545, (1), 399-426.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 左乙拉西坦杂质42 as an Impurity". Chemosphere, 2013, 489, 251-277.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Levetiracetam Impurity 42 Using HRMS and NMR". J. Nat. Prod., 2024, 109, (10), 7994-8003.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 左乙拉西坦杂质42 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2020, 562, 3648-3664.